SYRE
NASDAQ HealthcareSpyre Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $40.41 |
|---|---|
| Volume | 687,682 |
| Market Cap | 3.17B |
| Beta | 3.120 |
| RSI (14-Day) | 36.4 |
| 200-Day MA | $24.13 |
| 50-Day MA | $35.77 |
| 52-Week High | $45.76 |
| 52-Week Low | $10.91 |
| Forward P/E | -13.39 |
| Price / Book | 5.65 |
🎯 Investment Strategy Scores
How SYRE scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
1/100
High dividend yield + low volatility
🚀 Moon Shot
98/100
High growth potential (high beta + oversold)
🔪 Falling Knife
12/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
46/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
50/100
Large-cap, institutional-quality stocks
Find SYRE in your text
Paste any text on the homepage — the tool will extract SYRE and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.